5217.0000 -41.00 (-0.78%)
NSE Apr 06, 2026 15:00 PM
Volume: 57,708
 

5217.00
-0.78%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 589 to 613 in Dec 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended